Back to Startups

Pathos AI

About Pathos AI

Pathos AI is a Boston-based biotech company focused on AI-driven oncology, leveraging advanced artificial intelligence to enhance cancer treatment and research.

Business Information
Target Customers
healthcare providers research institutions pharmaceutical companies
Industry Categories
Bioscience & Disease Healthcare Systems AI, ML, Gen AI
Business Model
Revenue Model B2B partnerships and collaborations
Pricing Strategy N/A
Sales Channels direct sales, partnerships with healthcare organizations
Funding Timeline
Round Date Amount Investors
Series D May 15, 2025 $365.0M Unknown
Founders

No founder information available.

Investors

No investor information available.

Recent Mentions
BioTechVisions
BioTech Visionary @BioTechVisions
May 15, 2025

🚀 Pathos AI Secures $365M Series D Funding to Advance AI-Driven Oncology Pipeline Boston-based biotech company Pathos AI has raised $365 million in a Series D funding round, elevating its post-money valuation to approximately $1.6 billion. The capital infusion will support the https://t.co/xJZQgllzeX

raisingfi
Raising.fi @raisingfi
May 21, 2025

New Raise 🏛️ Company: Pathos AI 🔗 Website: https://t.co/8F6NkE6aco 📊 Amount: $365 Million 🔄 Round: Series D 🧮 Valuation: $1.6 Billion ⚙️ Industry: Biotechnology, AI